GAVI names deputy CEO; HIV-positive women respond well to Gardasil;

> The GAVI Alliance has named Anuradha Gupta, formerly the director of India's National Health Mission, as its deputy CEO. Release

> HIV-positive women respond well to Merck's ($MRK) HPV vaccine Gardasil, a study found. More

> Mucosis has entered into a collaboration and licensing agreement with China's Changchun BCHT Biotechnology Co. for its RSV prevention candidate and its Mimopath platform for other disease targets. Release

> A single, inhaled dose of an engineered protein developed by investigators at St. Jude Children's Research Hospital and the University of St. Andrews in the United Kingdom protected mice from a lethal infection with the 2009 H1N1 pandemic virus. Abstract

> NIH is funding an influenza research and surveillance network to improve pandemic preparedness. Release

> FDA scientists have developed an alternative assay that could speed the release of pandemic flu vaccines to the public. More

> Emergent BioSolutions ($EBS) has finished the last licensure-enabling study in a program for its anthrax jab, BioThrax, and submitted the final clinical study report to the Biomedical Advanced Research and Development Authority (BARDA) and the FDA. Release

> DCVax developer Northwest Bio ($NWBO) has secured financing to accelerate the expansion of its European manufacturing. Release

And Finally... Jenny McCarthy made headlines this week, claiming in a piece for the Chicago Sun-Times that she is "not 'anti-vaccine.'" Piece

On-Demand Webinar

Leveraging A Medical Record-Enriched Patient Dataset for COVID-19 Research

You are invited to join a webinar that will explore the ways researchers can leverage this enriched dataset for important COVID-19 research. Sign up today for this informative webinar to learn how you can leverage one of the only medical record reviews solely using real-world data from hospitalized COVID-19 patients.

Suggested Articles

Life sciences companies have pivoted quickly during COVID-19 - Syneos Health® is supporting more than 80 active COVID-19 projects, including vaccines.

Iowa State University is working on a room-temp-stable nasal spray vaccine for COVID-19, and it recently tapped device maker Zeteo for support.

Pfizer's shot will go before an FDA expert panel on Dec. 10, with Moderna's review pegged for the 17th, Warp Speed chief Moncef Slaoui, Ph.D., said.